Xmet-Trio 500/0.2/2 Tablet ER

By Xmet-Trio

Rx

10 Tablet ER in a Strip

Composition icon

Composition

Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Glenmark Pharmaceuticals Ltd icon

Manufacturer - Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after icon

Expires on or after

February, 2026

About Xmet-Trio 500/0.2/2 Tablet ER

Xmet-Trio 500/0.2/2 Tablet ER is a medication that falls under the category of anti-diabetic drugs. It is specifically designed for adults who are dealing with type 2 diabetes mellitus, a condition that affects the body's ability to regulate blood sugar levels effectively. This medication works by helping to control and maintain stable blood sugar levels in individuals with diabetes.

It is essential to take Xmet-Trio 500/0.2/2 Tablet ER with food consistently at the same time each day to maximize its benefits. Your doctor will determine the appropriate dosage for you, which may need adjustments based on how well the medication is managing your blood sugar levels over time. It is crucial to continue taking this medication as prescribed, even if you feel healthy or your blood sugar levels seem under control. Abruptly stopping the medication without consulting your doctor can lead to elevated blood sugar levels, increasing the risk of severe complications such as kidney damage, vision problems, nerve issues, and limb loss.

In addition to medication, a comprehensive treatment plan for diabetes should include a balanced diet, regular physical activity, and weight management as advised by your healthcare provider. Lifestyle factors play a significant role in managing diabetes effectively.

Common side effects of Xmet-Trio 500/0.2/2 Tablet ER include experiencing low blood sugar levels (hypoglycemia). It is important to be aware of symptoms such as sweating, dizziness, headache, and shaking, and know how to address them promptly. It is recommended to have regular meals and carry a fast-acting glucose source like sugary food or fruit juice to prevent low blood sugar episodes. Avoiding alcohol is also crucial as it can increase the risk of hypoglycemia. Other potential side effects may include changes in taste perception, nausea, diarrhea, stomach discomfort, headaches, swelling, blurred vision, bone fractures, and respiratory tract infections. Some individuals may notice weight gain while using this medication.

It is vital not to take Xmet-Trio 500/0.2/2 Tablet ER if you have type 1 diabetes mellitus, diabetic ketoacidosis, or severe kidney or liver issues. It is also important to inform your doctor if you have a history of heart disease before starting this medication. Pregnant or breastfeeding individuals should consult their healthcare provider before using this medication. Regular monitoring of blood sugar levels and potential blood tests may be recommended by your doctor to ensure the medication's effectiveness and monitor any adverse effects on blood cell counts and liver function.


Benefits

Xmet-Trio 500/0.2/2 Tablet ER is a medication used in the treatment of Type 2 diabetes mellitus. This medicine plays a crucial role in controlling high blood glucose levels, which is essential for managing diabetes. By slowing down the breakdown of food in the intestine into simple glucose and facilitating the removal of excess glucose through urine, Xmet-Trio 500/0.2/2 Tablet ER helps in stabilizing blood sugar levels post meals. Managing blood glucose effectively with this medication can significantly reduce the risk of serious complications associated with diabetes such as kidney damage, eye problems, nerve issues, and limb amputation. Additionally, for individuals with Type 2 diabetes and existing cardiovascular disease, Xmet-Trio 500/0.2/2 Tablet ER can lower the risk of death from cardiovascular issues.


Comprised of Glimepiride, Metformin, and Voglibose, Xmet-Trio 500/0.2/2 Tablet ER combines the actions of these three components to provide comprehensive benefits in diabetes management. Glimepiride, a sulfonylurea, stimulates insulin release from the pancreas. Metformin, a biguanide, reduces glucose production in the liver, delays glucose absorption from the intestines, and enhances the body's response to insulin. Voglibose, an alpha-glucosidase inhibitor, prevents complex sugars from converting into simple sugars like glucose in the intestine. By preventing blood glucose levels from spiking to dangerous levels, this medication helps in controlling diabetes and reducing the risk of complications such as kidney damage, blindness, and neuropathy. Additionally, Xmet-Trio 500/0.2/2 Tablet ER also lowers the likelihood of heart attacks and strokes. The combination of these three drugs in a single tablet simplifies the treatment regimen, making it easier for individuals to adhere to their medication schedule, promoting a healthier and more manageable life when used consistently alongside a proper diet and exercise routine. It is important to continue taking Xmet-Trio 500/0.2/2 Tablet ER as prescribed to uphold future health protection and optimize the benefits offered by this medication.


How to use the Xmet-Trio 500/0.2/2 Tablet ER

To use Xmet-Trio 500/0.2/2 Tablet ER, make sure to follow your doctor's directions carefully. Take this medicine on an empty stomach with a full glass of water. It is important not to chew, crush, or break the tablet; swallow it whole. Your physician will determine the right dose and duration based on factors such as your age, weight, and the condition being treated. Remember, proper usage of this medicine is crucial for its effectiveness, so it is essential to adhere to your doctor's instructions for the best results.


Uses of Xmet-Trio 500/0.2/2 Tablet ER

Xmet-Trio 500/0.2/2 Tablet ER is primarily used for the treatment of Type 2 diabetes mellitus. It is specifically indicated for adults with Type 2 diabetes when traditional methods such as diet, exercise, or initial medication do not effectively control blood sugar levels. In such cases, Xmet-Trio 500/0.2/2 Tablet ER can be used as a second line treatment either alone or as an additional therapy alongside another medication. This medication plays a crucial role in helping patients manage their blood sugar levels and overall condition of Type 2 diabetes mellitus.


What conditions Xmet-Trio 500/0.2/2 Tablet ER treats?

Xmet-Trio 500/0.2/2 Tablet ER is used for treating Diabetes Mellitus type 2. This condition occurs when the body either doesn't make enough insulin or doesn't respond well to insulin. Symptoms may include fatigue, thirst, blurred vision, and frequent urination. Complications of type 2 diabetes can involve skin infections, eye issues, nerve damage, foot ulcers, kidney problems, high blood pressure, and stroke.


Should you consult a doctor?

You should seek a doctor if you have any acute metabolic acidosis conditions like lactic acidosis or diabetic ketoacidosis. It is also advisable to consult a doctor if you are experiencing severe dehydration, infection, or shock. Seeking medical advice is crucial if you have severe ketosis or diabetic coma, or if you have a history of severe infections, trauma, or gastrointestinal obstruction.


Inform your doctor before taking Xmet-Trio 500/0.2/2 Tablet ER if you have had recent trauma, any upcoming surgery, febrile infections, or uncontrolled diabetes. It's important to mention if you are undernourished, have irregular meal patterns, or if you have hypothyroidism. If you have a history of abdominal surgery or intestinal disorders, consult your doctor before starting this medication. If you experience persistent fever, seeking medical help is recommended.


Side effects of Xmet-Trio 500/0.2/2 Tablet ER

When taking Xmet-Trio 500/0.2/2 Tablet ER, you may experience some side effects. These side effects are usually temporary and may go away as your body gets used to the medicine. Common side effects include nausea, diarrhea, abdominal pain, hypoglycemia (low blood sugar levels), loss of appetite, metallic taste in the mouth, and headache. There is also a possibility of experiencing stomach pain, flatulence, and upper respiratory symptoms. In rare cases, severe hypoglycemia (very low blood sugar) or signs of lactic acidosis (increase in lactic acid in the bloodstream) may occur, which require immediate medical attention. Additionally, signs of hypersensitivity reactions like rash, itching, anemia, low platelet count, and low white blood cell count have been reported. If you notice any of these serious side effects, stop taking the medication and consult your doctor promptly for appropriate management.


Safety advice

scroll

liver

When using Xmet-Trio 500/0.2/2 Tablet ER, it is important to be cautious if you have liver disease. Your doctor may need to adjust the dose of the medication. Typically, Xmet-Trio 500/0.2/2 Tablet ER is initiated at a low dose for individuals with mild to moderate liver disease. It is not advisable to use this medication if you have severe liver disease. Please consult your doctor for personalized guidance on the appropriate use of Xmet-Trio 500/0.2/2 Tablet ER in case of liver issues.

scroll

kidney

Xmet-Trio 500/0.2/2 Tablet ER may not be safe for use in patients with kidney disease. It is not recommended for those with severe kidney disease. Please consult your doctor before taking this medication.

scroll

alcohol

It is not safe to drink alcohol while taking Xmet-Trio 500/0.2/2 Tablet ER. Mixing alcohol with this medication can be harmful.

scroll

driving

When taking Xmet-Trio 500/0.2/2 Tablet ER, be cautious while driving as your blood sugar levels can impact your ability to drive. Avoid driving if you experience low or high blood sugar symptoms.

scroll

pregnancy

Xmet-Trio 500/0.2/2 Tablet ER may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication during pregnancy.

scroll

breastfeeding

Caution is advised while breastfeeding as Xmet-Trio 500/0.2/2 Tablet ER is likely unsafe. Limited human data indicates potential harm to the baby through breastmilk passage.


Age above 75(Geriatrics)

Xmet-Trio 500/0.2/2 Tablet ERshould be used with caution in elderly patients (aged 65 years and above). Consult your doctor before takingXmet-Trio 500/0.2/2 Tablet ER .


Age below 6 months(Pediatrics)

Xmet-Trio 500/0.2/2 Tablet ER is not recommended for use in children and adolescents (aged below 18 years) since the safety and effectiveness of the medicine are not established. Consult your doctor before taking Xmet-Trio 500/0.2/2 Tablet ER.


Consumption warning before consuming Xmet-Trio 500/0.2/2 Tablet ER

Before consuming Xmet-Trio 500/0.2/2 Tablet ER, it is important to be aware of potential risks. Some diabetic patients may develop lactic acidosis, a serious condition where there is an accumulation of lactic acid in the blood. Proper liver and kidney function are necessary to eliminate excess lactic acid. If you have kidney disease, indicated by a blood test, it is advised not to take Xmet-Trio 500/0.2/2 Tablet ER. These tablets may also lower vitamin B12 levels, so annual blood tests are recommended. When used with or without insulin, Xmet-Trio 500/0.2/2 Tablet ER can significantly decrease blood sugar levels, prompting a possible adjustment in insulin dosage by your doctor. Additionally, these tablets may lower thyroid-stimulating hormone (TSH) levels, so an annual TSH check-up is recommended to monitor thyroid function.


What if you forgot to take Xmet-Trio 500/0.2/2 Tablet ER?

If you forget to take a dose of Xmet-Trio 500/0.2/2 Tablet ER, you should try to take it as soon as you remember. But if it's nearly time for your next scheduled dose, it's better to skip the missed one and continue with your usual dosing routine. Avoid taking a double dose to make up for the missed one. It's important to stick to the prescribed schedule to maintain the effectiveness of the medication.


What happens if you take overdose of Xmet-Trio 500/0.2/2 Tablet ER?

In the event that you take an excessive amount of Xmet-Trio 500/0.2/2 Tablet ER, it is important to seek immediate medical attention by consulting your doctor or visiting the nearest hospital. Overdose symptoms may include hypoglycemia (low blood sugar), lactic acidosis, pancreatitis (inflammation of the pancreas), abdominal discomfort, and diarrhea. If you suspect an overdose or experience any of these symptoms, do not delay in seeking help to ensure proper medical care.


Related lab tests

Related Lab Tests for monitoring the effectiveness and safety of Xmet-Trio 500/0.2/2 Tablet ER may include:

- Blood Glucose - Fasting

- Blood Glucose - Postprandial

- Glycosylated Hemoglobin (HbA1C)


These tests help healthcare providers evaluate how well the medication is managing blood sugar levels over time. Fasting blood glucose test measures sugar levels after not eating for a period, while postprandial blood glucose test evaluates sugar levels after meals. Glycosylated Hemoglobin test provides an average of blood sugar levels over the past 2-3 months. Regular monitoring of these lab tests is essential for effective diabetes management with Xmet-Trio 500/0.2/2 Tablet ER.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

179

Inclusive of all taxes

Content verified by

chevron-right

Dr. Upasana Bhatia

MBBS - General Medicine

Last update on 01-Oct-2024